FUSI FABIO

Office hours

  • Monday from 11:00 to 13:00
    Place: Studio del docente - Polo Scientifico Universitario di San Miniato
    Note: Previo appuntamento
The Professor receives by appointment by email.

Contacts

0577235377 [int.5377] (Lab Patch 1),0577235203 [int.5203] (Ufficio),0577232375 [int.2375] (Lab Patch 2)

Curriculum Vitae

Teaching activities

Completion accademic year: 2026/2027

Course year: 4 Full cicle (5 years) CHIMICA E TECNOLOGIA FARMACEUTICHE A.Y. 2023/2024
Course year: 4 Full cicle (5 years) CHIMICA E TECNOLOGIA FARMACEUTICHE A.Y. 2023/2024
Course year: 4 Full cicle (5 years) CHIMICA E TECNOLOGIA FARMACEUTICHE A.Y. 2023/2024

Completion accademic year: 2025/2026

Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023

Completion accademic year: 2024/2025

Research

Ultime pubblicazioni:

  • Carullo, G., Falbo, F., Tudino, V., Song, J., Fava, M., Fontana, A., et al. (2026). Targeting class I histone deacetylases triggers antitumor responses in colorectal cancer in vitro and in vivo. JOURNAL OF MEDICINAL CHEMISTRY, 69(2), 1049-1074 [10.1021/acs.jmedchem.5c02237]. - view more
  • Fusi, F., Saponara, S., Carullo, G., Panti, A., Bichicchi, A., Pifferi, A., et al. (2025). The insulin-releasing agent quercetin-3-oleate stimulates CaV1.2 channels similarly to quercetin, though with a reduced vasorelaxant activity. EUROPEAN JOURNAL OF PHARMACOLOGY, 1003 [10.1016/j.ejphar.2025.177902]. - view more
  • Gentile, M., Panti, A., Paccagnini, E., Lupetti, P., Bova, S., Fusi, F. (2025). Ba2+-Induced Vasoconstriction as a Model to Investigate the Dynamin Dependence of Biological Processes Regulating Vascular Tone. PHARMACOLOGY RESEARCH & PERSPECTIVES, 13(6) [10.1002/prp2.70184]. - view more
  • Ibba, R., Sestito, S., Ambrosio, F.A., Marchese, E., Costa, G., Fiorentino, F.P., et al. (2024). Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 276 [10.1016/j.ejmech.2024.116647]. - view more
  • Falbo, F., Carullo, G., Panti, A., Spiga, O., Gianibbi, B., Ahmed, A., et al. (2024). Exploring the chemical space around chrysin to develop novel vascular CaV1.2 channel blockers, promising vasorelaxant agents. ARCHIV DER PHARMAZIE, 357(11) [10.1002/ardp.202400536]. - view more